trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['rectal', 't-dxd', 'colorectal']
 there s definitely the patients with her2-mutant #colorectalcancer that we need to do trials/treatments for. often the cases i ve seen are young onset rectal cancer specifically. industry partners with her2 should look into this. we have an nci trial with t-dxd. #asco23
Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼‍🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO📍 #GI23